Website Header with Language Selector and Dropdowns

Avapritinib
CAT No: CL-AVPR-001 CAS No: 1703793-34-3 Mol Wt: 498.6 Mol F: C26H27FN10 Inv Status: Custom Synthesis
Chemical Name: (S)-1-(4-Fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-1-yl)pyrimidin-5-yl)ethan-1-amine
Avapritinib Impurity 1
CAT No: CL-AVPR-002 CAS No: NA Mol Wt: 514.6 Mol F: C26H27FN10O Inv Status: Custom Synthesis
Chemical Name: (S)-N-(1-(4-Fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-1-yl)pyrimidin-5-yl)ethyl)hydroxylamine
Avapritinib Impurity 2
CAT No: CL-AVPR-003 CAS No: NA Mol Wt: 690.7 Mol F: C32H35FN10O7 Inv Status: Custom Synthesis
Chemical Name: (2R,3R,4R,5S,6R)-6-((((S)-1-(4-Fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-1-yl)pyrimidin-5-yl)ethyl)amino)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid
Avapritinib Impurity 3
CAT No: CL-AVPR-004 CAS No: 1703793-31-0 Mol Wt: 498.6 Mol F: C26H27FN10 Inv Status: Custom Synthesis
Chemical Name: 4-(4-(5-(2-(4-fluorophenyl)propan-2-yl)pyrimidin-2-yl)piperazin-1-yl)-7-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a][1,3,5]triazine
Avapritinib Impurity 4
CAT No: CL-AVPR-005 CAS No: 1703795-41-8 Mol Wt: 479.5 Mol F: C27H22FN7O Inv Status: Custom Synthesis
Chemical Name: (2-(4-(6-(4-fluorophenyl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-1-yl)pyrimidin-5-yl)(phenyl)methanone
Avapritinib Impurity 5
CAT No: CL-AVPR-006 CAS No: 1703793-18-3 Mol Wt: 485.5 Mol F: C25H24FN9O Inv Status: Custom Synthesis
Chemical Name: (R)-(4-Fluorophenyl)(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-1-yl)pyrimidin-5-yl)methanol
Avapritinib D3
CAT No: CL-AVPR-007 CAS No: NA Mol Wt: 501.6 Mol F: C26H24D3FN10 Inv Status: Custom Synthesis
Chemical Name: (S)-1-(4-Fluorophenyl)-1-(2-(4-(6-(1-(methyl-d3)-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-1-yl)pyrimidin-5-yl)ethan-1-amine
Subscribe for news letter:
  

© Cleanchem Laboratories LLP. All Rights Reserved.